Trial Profile
Effect of dabigatran or rivaroxaban on activated clotting times during atrial ablation procedures in patients with renal impairment
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 20 Feb 2017
Price :
$35
*
At a glance
- Drugs Dabigatran etexilate (Primary) ; Rivaroxaban (Primary)
- Indications Arrhythmias; Stroke
- Focus Adverse reactions
- 20 Feb 2017 New trial record